Page last updated: 2024-09-03

ly 255283 and itraconazole

ly 255283 has been researched along with itraconazole in 1 studies

Compound Research Comparison

Studies (ly 255283)	Trials (ly 255283)	Recent Studies (post-2010) (ly 255283)	Studies (itraconazole)	Trials (itraconazole)	Recent Studies (post-2010) (itraconazole)
54	0	15	6,440	653	2,357

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, R; Steel, HC; Theron, AJ; Tintinger, GR	1

Other Studies

1 other study(ies) available for ly 255283 and itraconazole

Article	Year
Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4. Clinical and experimental immunology, 2007, Volume: 150, Issue:1 Topics: Adenosine Triphosphate; Antifungal Agents; Calcium; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Humans; Indoles; Itraconazole; Leukotriene Antagonists; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Spectrometry, Fluorescence; Tetrazoles	2007

Article

Year

Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4.

Clinical and experimental immunology, 2007, Volume: 150, Issue:1

Topics: Adenosine Triphosphate; Antifungal Agents; Calcium; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Humans; Indoles; Itraconazole; Leukotriene Antagonists; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Spectrometry, Fluorescence; Tetrazoles

2007